SOUTH SAN FRANCISCO, Calif., November 29, 2016 – Fluidigm Corporation (NASDAQ:FLDM) today announced that it will webcast the company’s presentation at the Piper Jaffray 28th Annual Healthcare Conference in New York City on November 30, 2016. Chris Linthwaite, President and Chief Executive Officer, will participate in a 25-minute question-and-answer session scheduled to begin at 12:30 PM ET.

 

The webcast can be accessed at: http://edge.media-server.com/m/p/2zv6dc6r. 

The webcast will be archived for 90 days following the live presentation.

 

About Fluidigm 

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. We sell to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

 

We use our website (www.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (https://www.facebook.com/fluidigm), and LinkedIn page (https://www.linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts. 

 

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.

 

Contact 

Ana Petrovic 

Director, Corporate Development and Investor Relations 

650.243.6628 (Office) 

ana.petrovic@fluidigm.com